SYMPOSIA

The organizers are pleased to announce that following adjudication by the International Scientific Committee the following symposia have been selected for presentation at the meeting.

POPULATION PHARMACOGENETICS
AND ITS CLINICAL IMPLICATION IN PSYCHIATRY

Chair

• Adrián Llerena, Spain

Speakers:

• Martin A. Kennedy, Department of Pathology, University of Otago, Christchurch, New Zealand
• Vural Özdemir, Research Group on Complex Collaboration in Health, Faculties of Management and Medicine, McGill University, QC, Canada
• Mara Helena Hutz, Genetics Department, Biosciences Institute, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
• Adrián Llerena, Clinical Research Centre University, Hospital University of Extremadura Medical School, Badajoz, Spain

NOVEL BIOMARKERS OF THERAPEUTIC EFFICACY
FOR MOOD AND PSYCHOSIS DISORDERS

Chair

• Dorit Ben-Shachar, Israel

Speakers

• Dorit Ben-Shachar, Laboratory of Psychobiology, Department of Psychiatry, Faculty of Medicine, Rambam Health Care Campus and Technion- Israel Institute of Technology, Haifa, Israel
• Mark Rasenick, Department of Physiology & Biophysics and Psychiatry, University of Illinois, College of Medicine at Chicago, IL, USA
• Maurizio Popoli, Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milan, Italy
• Rainer Rupprecht, Department of Psychiatry and Psychotherapy, University Regensburg, Germany

GLUTAMATERGIC ANTIPSYCHOTIC MECHANISMS: FROM THEORY TO PRACTICE

Chair

• Uriel Heresco-Levy, Israel

Speakers

• Uriel Heresco-Levy, Department of Psychiatry, Hadassah Medical School, Hebrew University and Ezrath Nashim - Herzog Memorial Hospital, Jerusalem, Israel
• Kenji Hashimoto, Department of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan
• Kim Q. Do, Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Lausanne, Switzerland
• Bita Moghaddam, Department of Neuroscience and Psychiatry University of Pittsburgh, Pittsburgh, PA, USA

FROM NEUROBIOLOGY TOWARDS PERSONALIZED MEDICINE IN ADHD

Chair

• Andreas Reif, Germany

Speakers

• Phil Asherson, MRC Social Genetic and Developmental Psychiatry, Institute of Psychiatry, King's College London, UK
• Claiton H.D. Bau, Department of Genetics, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
• J. Antoni Ramos-Quiroga, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain
• Andreas Reif, Department of Psychiatry, University of Würzburg, Germany

PHARMACOGENOMICS OF ANTIPSYCHOTIC DRUG-INDUCED METABOLIC DISTURBANCES

Chair

• Gavin Reynolds, UK

Speakers

• Gavin Reynolds, Biomedical Research Centre, Sheffield Hallam University, UK
• Jim Kennedy, Department of Neuroscience, Centre for Addiction and Mental Health, University of Toronto, Canada
• Weihua Yue, Institute of Mental Health, Peking University, China
• Erika L. Nurmi, Department of Psychiatry and Biobehavioral Sciences University of California, Los Angeles, CA, USA

INFLAMMATORY BIOMARKERS AS PREDICTIVE OF DEPRESSION, COGNITIVE FUNCTION AND TREATMENT RESPONSE

Chair

• Patricia A. Zunszain, UK

Speakers

• Annamaria Cattaneo, Department of Biomedical Sciences and Biotechnology, Biology and Genetic Section, University of Brescia, Italy
• Kuan-Pin Su, Department of General Psychiatry, Institute of Neural and Cognitive Sciences, China Medical University & Hospital, Taichung, Taiwan
• Patricia A. Zunszain, Department of Psychological Medicine, Institute of Psychiatry, King's College London, UK
• Bernhard Baune, Department of Discipline of Psychiatry, School of Medicine, University of Adelaide, Australia

BRAIN STIMULATION: NOVEL APPROACHES TO PERSONALIZED MEDICINE

Chair

• Harold Sackeim, USA

Speakers:

• Harold Sackeim, Department of Psychiatry and Radiology, Columbia University, New York, NY, USA
• Abraham Zangen, Department Life Sciences, Ben Gurion University,
  Beer Sheva, Israel
• Thomas Schlaepfer, Department of Psychiatry, University of Bonn, Germany
• Mark George, Department of Psychiatry and Neurology, Medical University of South Carolina, Charleston, SC, USA

PHARMACOGENOMICS AND TRANSLATIONAL MEDICINE IN DELAY OF ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S DISEASE

Chair

• Iris Grossman, Israel

Speakers:

• Allen Roses, Zinfandel Pharmaceuticals, Inc., Chapel Hill, NC, USA
• Iris Grossman, IsraGene Ltd., Rosh HaAyin, Israel
• Andreas Monsch, Memory Clinic, Department of Geriatrics, University Hospital Basel, Switzerland
• Stephen Brannan, Pharmaceutical Development, Takeda Pharmaceuticals International, Inc., Deerfield, IL USA

PHARMACOGENOMICS AND ADDICTION:
ARE WE THERE YET?

Chair

• Henry R. Kranzler, USA

Speakers:

• Henry R. Kranzler, Treatment Research Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
• Caryn Lerman, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
• Joel Gelernter, Department of Psychiatry, New Haven, Yale University, CT, USA
• Wim van den Brink, Department of Psychiatry, Amsterdam Institute for Addiction Research, The Netherlands